195 related articles for article (PubMed ID: 11113386)
1. Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?
Compston JE
Bone; 2000 Dec; 27(6):765-8. PubMed ID: 11113386
[No Abstract] [Full Text] [Related]
2. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.
Hodsman AB; Hanley DA; Josse R
CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412
[No Abstract] [Full Text] [Related]
3. Risedronate prevents hip fractures, but who should get therapy?
Deal CL
Cleve Clin J Med; 2002 Dec; 69(12):964, 968-70, 973-6. PubMed ID: 12546269
[TBL] [Abstract][Full Text] [Related]
4. Risedronate treatment and extended fracture protection in postmenopausal women.
Harris ST
Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
[No Abstract] [Full Text] [Related]
5. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
6. [Bisphosphonate treatment prevents hip fractures in 70-79 year old women with osteoporotic vertebral fractures].
Netelenbos JC
Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1336-8. PubMed ID: 11484428
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
Papapoulos SE
Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
[No Abstract] [Full Text] [Related]
8. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporosis].
Bartl R
Internist (Berl); 2002 Dec; 43(12):1529-30, 1533-43. PubMed ID: 12607392
[No Abstract] [Full Text] [Related]
10. [Osteoporosis in the elderly--diagnosis and treatment].
Gärtner R
MMW Fortschr Med; 2005 Feb; 147(7):33, 35-6. PubMed ID: 18441582
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.
Silverman SL; Watts NB; Delmas PD; Lange JL; Lindsay R
Osteoporos Int; 2007 Jan; 18(1):25-34. PubMed ID: 17106785
[TBL] [Abstract][Full Text] [Related]
12. Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women.
Reginster JY
Clin Exp Rheumatol; 2001; 19(2):121-2. PubMed ID: 11326471
[No Abstract] [Full Text] [Related]
13. Prevention and treatment of osteoporosis.
Lloyd M
Clin Med (Lond); 2001; 1(2):155-6. PubMed ID: 11333463
[No Abstract] [Full Text] [Related]
14. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
15. Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture.
Cadarette SM; Katz JN; Brookhart MA; Stürmer T; Stedman MR; Solomon DH
Ann Intern Med; 2008 May; 148(9):637-46. PubMed ID: 18458276
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.
Reginster J; Minne HW; Sorensen OH; Hooper M; Roux C; Brandi ML; Lund B; Ethgen D; Pack S; Roumagnac I; Eastell R
Osteoporos Int; 2000; 11(1):83-91. PubMed ID: 10663363
[TBL] [Abstract][Full Text] [Related]
17. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
[No Abstract] [Full Text] [Related]
18. Effectiveness of risedronate and alendronate on nonvertebral fractures: an observational study through 2 years of therapy.
Lindsay R; Watts NB; Lange JL; Delmas PD; Silverman SL
Osteoporos Int; 2013 Aug; 24(8):2345-52. PubMed ID: 23612793
[TBL] [Abstract][Full Text] [Related]
19. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
[TBL] [Abstract][Full Text] [Related]
20. Summaries for patients. Drug therapy for osteoporosis.
Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
[No Abstract] [Full Text] [Related]
[Next] [New Search]